State Street’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $111M | Buy |
|
|||||
|
2025
Q2 | $93.5M | Sell |
|
|||||
|
2025
Q1 | $94.8M | Sell |
|
|||||
|
2024
Q4 | $115M | Buy |
|
|||||
|
2024
Q3 | $148M | Sell |
|
|||||
|
2024
Q2 | $111M | Sell |
|
|||||
|
2024
Q1 | $133M | Sell |
|
|||||
|
2023
Q4 | $156M | Buy |
|
|||||
|
2023
Q3 | $91.5M | Buy |
|
|||||
|
2023
Q2 | $114M | Sell |
|
|||||
|
2023
Q1 | $110M | Sell |
|
|||||
|
2022
Q4 | $136M | Buy |
|
|||||
|
2022
Q3 | $106M | Buy |
|
|||||
|
2022
Q2 | $147M | Buy |
|
|||||
|
2022
Q1 | $142M | Buy |
|
|||||
|
2021
Q4 | $141M | Buy |
|
|||||
|
2021
Q3 | $133M | Buy |
|
|||||
|
2021
Q2 | $131M | Sell |
|
|||||
|
2021
Q1 | $183M | Sell |
|
|||||
|
2020
Q4 | $232M | Sell |
|
|||||
|
2020
Q3 | $149M | Sell |
|
|||||
|
2020
Q2 | $155M | Sell |
|
|||||
|
2020
Q1 | $99M | Buy |
|
|||||
|
2019
Q4 | $93.9M | Buy |
|
|||||
|
2019
Q3 | $90.3M | Sell |
|
|||||
|
2019
Q2 | $135M | Buy |
|
|||||
|
2019
Q1 | $133M | Sell |
|
|||||
|
2018
Q4 | $89.2M | Buy |
|
|||||
|
2018
Q3 | $131M | Buy |
|
|||||
|
2018
Q2 | $127M | Sell |
|
|||||
|
2018
Q1 | $103M | Buy |
|
|||||
|
2017
Q4 | $74M | Buy |
|
|||||
|
2017
Q3 | $80.7M | Sell |
|
|||||
|
2017
Q2 | $95.4M | Buy |
|
|||||
|
2017
Q1 | $85.8M | Sell |
|
|||||
|
2016
Q4 | $98.2M | Sell |
|
|||||
|
2016
Q3 | $105M | Buy |
|
|||||
|
2016
Q2 | $62M | Sell |
|
|||||
|
2016
Q1 | $81.3M | Buy |
|
|||||
|
2015
Q4 | $110M | Buy |
|
|||||
|
2015
Q3 | $82.5M | Buy |
|
|||||
|
2015
Q2 | $85.7M | Buy |
|
|||||
|
2015
Q1 | $32.3M | Sell |
|
|||||
|
2014
Q4 | $23.1M | Buy |
|
|||||
|
2014
Q3 | $21.4M | Buy |
|
|||||
|
2014
Q2 | $4.12M | Buy |
|
|||||
|
2014
Q1 | $3.13M | Buy |
|